Simon Gross
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?(2013)273 cited
- Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract.(2002)
- → Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes(2015)67 cited
- → Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice(2014)66 cited
- → Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin(2015)27 cited
- → A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-β1(2015)21 cited
- → Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model(2014)20 cited
- → Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis(2024)1 cited
- → Expression of Amyloid Beta42 and its metabolizing proteins is alteredin steatosis and non-alcoholic steatohepatitis (NASH)(2022)
- → Neuromedin U Receptor 2 orchestrates sleep continuity and circadian entrainment(2025)